Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma

Cancer Research

Volumn 62, Issue 2, 2002, Pages 589-596

  Qian, Chao Nan ^a,b   Guo, Xiang ^a,b   Chen, Jindong ^a   Teh, Bin Tean ^a   Cao, Brian ^a   Kort, Eric J ^a   Resau, James H ^a   Lee, Chong Chou ^a   Wang, Ling Mei ^a   Vande Woude, George F ^a   Mai, Wei Yuan ^b,c   Min, Hua Qing ^b   Hong, Ming Huang ^b  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MUTATION; NASOPHARYNX CARCINOMA; NOSE MUCOSA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; SIGNAL TRANSDUCTION; SQUAMOUS EPITHELIUM; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; BIOPSY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MUTATION; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; RNA, MESSENGER; SURVIVAL RATE;

EID: 0037081204     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Nasopharyngeal cancer: Epidemiology, staging, and treatment
2. Nasopharyngeal carcinoma
3. Nasopharyngeal carcinoma
4. Nasopharyngeal carcinoma: Genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients
5. Nasopharyngeal cancer
6. Histological typing of tumors of the upper respiratory tract and ear
7. Histopathology of nasopharyngeal carcinoma: Correlations with epidemiology, survival rates, and other biological characteristics
8. Infiltrating lymphocytes and assessory cells in nasopharyngeal carcinoma
9. Correlations between histopathological and biological findings in nasopharyngeal carcinom and a its prognostic significance
10. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure
11. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma
12. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
13. Molecular cloning of a new transforming gene from a chemically transformed human cell line
14. The human met oncogene is related to the tyrosine kinase oncogenes
15. Gene structure of the human MET proto-oncogene
16. Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met
17. Activating mutations for the met tyrosine kinase receptor in human cancer
18. The mutationally activated Met receptor mediates motility and metastasis
19. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
20. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene
21. Novel mutations of the MET proto-oncogene in papillary renal carcinomas
22. Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family
23. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
24. A novel germ line juxtamembrane met mutation in human gastric cancer
25. Tyrosine kinase receptor indistinguishable from the c-met protein
26. Biosynthesis of the protein encoded by the c-met proto-oncogene
27. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
28. Hepatocyte growth factor/scatter factor-induced intracellular signalling
29. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
30. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development
31. Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in cancer: Met oncogene expression and breast cancer as a model
32. Alteration of Met protooncogene product expression and prognosis in breast carcinomas
33. Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy
34. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas
35. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer
36. Expression of the MET/HGF receptor in normal and neoplastic human tissues
37. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain
38. Hepatocyte growth factor and its receptor (c-met) in prostatic carcinoma
39. Tumor angiogenesis, hepatocyte growth factor, and c-met expression in endometrial carcinoma
40. A new staging system for nasopharyngeal carcinoma in China
41. Detection of Epstein-Barr virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines
42. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas
43. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma
44. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx
45. Establishment and characterization of a xenografted nasopharyngeal carcinoma and corresponding epithelial cell line
46. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
47. Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor
48. Correction and quantification of normal differentiation in human epithelium: Application for Optimas 4.0 image analysis program
49. The interpretation of diagnostic tests
50. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
51. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma
52. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA
53. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors
54. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions
55. Hepatocyte growth factor/scatter factor: Its molecular, cellular, and clinical implications in cancer
56. Met expression and sarcoma tumorigenicity
57. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells
58. Nasopharyngeal carcinoma and lymphoinfiltration
59. Undifferentiated carcinoma of the nasopharynx: A light and electron microscopical study
60. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy
61. Primary study of neovasculature correlating with metastatic nasopharyngeal carcinoma using computer image analysis
62. Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470)
63. Anti-tumor effect of angiogenesis inhibitor TNP-470 on the human nasopharyngeal carcinoma cell line NPC/HK1
64. Combination of angiogenesis inhibitor TNP-470 with cytotoxic drugs in experimental therapy of nasopharyngeal carcinoma
65. Regulation of angiogenesis by scatter factor
66. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo
67. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma
68. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma